1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Approvals

FDA Approves Medtronic’s 'Extra-Vascular' ICD, The First Of Its Kind

 
• By Reed Miller

The Aurora EV ICD system provides anti-tachycardia pacing, cardioversion and defibrillation therapies through a lead placed under the breastbone, outside of the heart and veins.

• Source: Shutterstock

Medtronic’s Aurora EV ICD system will be the first extravascular implantable cardioverter defibrillator available in the US.

On 23 October, the US Food and Drug Administration approved Aurora to provide defibrillation shocks, anti-tachycardia pacing (ATP), and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation